Mice that genetically lacked CB1, CB2, or both, exhibited aggravated inflammation in the TNBS-induced colitis model [33], but blocking the degradation of endocannabinoids inhibited inflammation and reversed the shortening of the colon [29]. Here, CNR2 is linked to colitis.